BERG is a clinical-stage, AI-powered biotechnology company taking a bold ‘Back to Biology™, approach to healthcare. By leveraging our proprietary intelligence platform – Interrogative Biology®, our goal is to map disease and revolutionize treatments for patients around the world.

Choose from the options below to view our pipeline information.

The Interrogative Biology® platform in turn guides our Next Generation MedicineTM program that encompasses a portfolio of assets, including novel therapeutics, biomarker panels and diagnostic technologies, a data repository and a sample bank.